John is a clinical research and evidence strategy executive with more than 20 years of experience leading global clinical operations, late-phase research, real-world evidence (RWE), and commercialization-focused evidence generation programs across biopharmaceutical, medical device, CRO, and academic organizations. Throughout his career, he has built and led multi-hundred-million-dollar clinical and evidence portfolios, developed innovative operating models integrating new and emerging technologies, and transformed fragmented research functions into scalable, high-performing organizations. John is recognized for his expertise in strategic evidence generation, modern feasibility, portfolio governance, and aligning clinical research with business and commercialization objectives. He is a frequent speaker on clinical operations, RWE, and organizational transformation.